| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 4.15e-06 | 13 | 50 | 3 | GO:0031994 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.39e-05 | 19 | 50 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | insulin receptor activity | 1.84e-05 | 3 | 50 | 2 | GO:0005009 | |
| GeneOntologyMolecularFunction | insulin binding | 6.12e-05 | 5 | 50 | 2 | GO:0043559 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.05e-04 | 188 | 50 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | growth factor binding | 6.24e-04 | 156 | 50 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 6.32e-04 | 15 | 50 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 6.87e-04 | 430 | 50 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | protein antigen binding | 7.21e-04 | 16 | 50 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.13e-03 | 20 | 50 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.25e-03 | 323 | 50 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.26e-03 | 85 | 50 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 1.37e-03 | 22 | 50 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.55e-03 | 891 | 50 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.78e-03 | 25 | 50 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | hormone binding | 2.19e-03 | 103 | 50 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 2.39e-03 | 29 | 50 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | complement binding | 2.91e-03 | 32 | 50 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.38e-03 | 120 | 50 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | fibronectin binding | 4.08e-03 | 38 | 50 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.50e-03 | 268 | 50 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | protein transporter activity | 4.96e-03 | 42 | 50 | 2 | GO:0140318 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 5.20e-03 | 43 | 50 | 2 | GO:0043548 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 2.62e-06 | 40 | 50 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.27e-05 | 377 | 50 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.33e-05 | 378 | 50 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.38e-05 | 379 | 50 | 7 | GO:0045229 | |
| GeneOntologyCellularComponent | extracellular matrix | FRAS1 COL16A1 IMPG1 ADAMDEC1 ADAMTS3 ACAN LPA LTBP1 ADAMTS14 CTSB | 2.86e-06 | 656 | 50 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FRAS1 COL16A1 IMPG1 ADAMDEC1 ADAMTS3 ACAN LPA LTBP1 ADAMTS14 CTSB | 2.94e-06 | 658 | 50 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.02e-06 | 530 | 50 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | insulin receptor complex | 3.35e-05 | 4 | 50 | 2 | GO:0005899 | |
| GeneOntologyCellularComponent | plasma membrane raft | 4.20e-04 | 147 | 50 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | neuronal cell body | 7.59e-04 | 835 | 50 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.43e-03 | 519 | 50 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | cell body | 1.51e-03 | 929 | 50 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | membrane raft | 1.69e-03 | 362 | 50 | 5 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.74e-03 | 364 | 50 | 5 | GO:0098857 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 2.28e-03 | 1228 | 50 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | caveola | 2.38e-03 | 111 | 50 | 3 | GO:0005901 | |
| GeneOntologyCellularComponent | growth cone | 2.78e-03 | 245 | 50 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.12e-03 | 253 | 50 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.13e-03 | 817 | 50 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | cell surface | 4.56e-03 | 1111 | 50 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | side of membrane | 4.57e-03 | 875 | 50 | 7 | GO:0098552 | |
| GeneOntologyCellularComponent | endosome lumen | 4.76e-03 | 43 | 50 | 2 | GO:0031904 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.20e-03 | 45 | 50 | 2 | GO:0044295 | |
| MousePheno | abnormal mouth morphology | NCOA3 FLNA FRAS1 SALL3 ZFHX4 ADAMTS3 ACAN APMAP LRP2 LRP4 LTBP1 | 1.83e-06 | 670 | 40 | 11 | MP:0000452 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | MYT1L FLNA FRAS1 IGF1R SALL3 ZFHX4 ADAMTS3 ACAN MYT1 INSR LRP2 LRP4 LTBP1 SLC39A8 | 5.82e-06 | 1269 | 40 | 14 | MP:0011111 |
| MousePheno | abnormal palate morphology | 3.06e-05 | 321 | 40 | 7 | MP:0003755 | |
| MousePheno | abnormal facial morphology | NCOA3 FLNA FRAS1 SALL3 ZFHX4 ADAMTS3 ACAN APMAP LRP2 LRP4 LTBP1 | 3.37e-05 | 910 | 40 | 11 | MP:0003743 |
| MousePheno | abnormal gas homeostasis | 3.86e-05 | 600 | 40 | 9 | MP:0003948 | |
| MousePheno | abnormal craniofacial morphology | NCOA3 FLNA FRAS1 IGF1R SALL3 ZFHX4 ADAMTS3 ACAN APMAP LRP2 LRP4 LTBP1 ITGA4 | 7.07e-05 | 1372 | 40 | 13 | MP:0000428 |
| MousePheno | craniofacial phenotype | NCOA3 FLNA FRAS1 IGF1R SALL3 ZFHX4 ADAMTS3 ACAN APMAP LRP2 LRP4 LTBP1 ITGA4 | 7.07e-05 | 1372 | 40 | 13 | MP:0005382 |
| MousePheno | complete cleft palate | 7.94e-05 | 5 | 40 | 2 | MP:0021213 | |
| MousePheno | ventricular septal defect | 9.01e-05 | 261 | 40 | 6 | MP:0010402 | |
| MousePheno | neonatal lethality, complete penetrance | 1.12e-04 | 534 | 40 | 8 | MP:0011087 | |
| MousePheno | perimembraneous ventricular septal defect | 1.34e-04 | 92 | 40 | 4 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 1.40e-04 | 93 | 40 | 4 | MP:0008823 | |
| MousePheno | perinatal lethality, complete penetrance | 1.44e-04 | 712 | 40 | 9 | MP:0011089 | |
| MousePheno | cleft palate | 1.57e-04 | 289 | 40 | 6 | MP:0000111 | |
| MousePheno | oral cleft | 1.64e-04 | 291 | 40 | 6 | MP:0021164 | |
| MousePheno | digestive/alimentary phenotype | NCOA3 FLNA FRAS1 SALL3 ZFHX4 ADAMDEC1 ADAMTS3 ACAN LPA RTTN INSR LRP2 CTSB | 1.77e-04 | 1500 | 40 | 13 | MP:0005381 |
| MousePheno | abnormal head morphology | NCOA3 FLNA FRAS1 SALL3 ZFHX4 ADAMTS3 ACAN APMAP LRP2 LRP4 LTBP1 | 2.19e-04 | 1120 | 40 | 11 | MP:0000432 |
| MousePheno | brachypodia | 2.21e-04 | 8 | 40 | 2 | MP:0002772 | |
| MousePheno | abnormal cranium morphology | 3.89e-04 | 813 | 40 | 9 | MP:0000438 | |
| MousePheno | abnormal interventricular septum morphology | 3.90e-04 | 342 | 40 | 6 | MP:0000281 | |
| MousePheno | abnormal basicranium morphology | 4.08e-04 | 123 | 40 | 4 | MP:0010029 | |
| MousePheno | abnormal vagina morphology | 4.11e-04 | 51 | 40 | 3 | MP:0001139 | |
| MousePheno | cyanosis | 4.38e-04 | 226 | 40 | 5 | MP:0001575 | |
| MousePheno | abnormal craniofacial bone morphology | 4.41e-04 | 827 | 40 | 9 | MP:0002116 | |
| MousePheno | decreased autopod size | 5.17e-04 | 12 | 40 | 2 | MP:0014291 | |
| MousePheno | abnormal axial skeleton morphology | NCOA3 FLNA FRAS1 IGF1R SALL3 ZFHX4 PHF19 ADAMTS3 ACAN LRP2 LRP4 LTBP1 | 5.48e-04 | 1458 | 40 | 12 | MP:0002114 |
| MousePheno | abnormal heart septum morphology | 7.59e-04 | 388 | 40 | 6 | MP:0006113 | |
| MousePheno | abnormal oxygen level | 7.72e-04 | 256 | 40 | 5 | MP:0001574 | |
| MousePheno | decreased brown fat cell size | 8.19e-04 | 15 | 40 | 2 | MP:0009136 | |
| MousePheno | abnormal autopod size | 8.19e-04 | 15 | 40 | 2 | MP:0014290 | |
| MousePheno | decreased white fat cell size | 9.16e-04 | 67 | 40 | 3 | MP:0009133 | |
| MousePheno | persistent truncus arteriosus | 9.16e-04 | 67 | 40 | 3 | MP:0002633 | |
| MousePheno | abnormal aorticopulmonary septum morphology | 9.56e-04 | 68 | 40 | 3 | MP:0010650 | |
| MousePheno | aorticopulmonary septal defect | 9.56e-04 | 68 | 40 | 3 | MP:0010651 | |
| MousePheno | abnormal brown fat cell size | 1.06e-03 | 17 | 40 | 2 | MP:0009135 | |
| MousePheno | abnormal secondary palate morphology | 1.07e-03 | 159 | 40 | 4 | MP:0013550 | |
| MousePheno | decreased brown adipose tissue mass | 1.19e-03 | 18 | 40 | 2 | MP:0014169 | |
| MousePheno | abnormal lateral ventricle morphology | 1.20e-03 | 164 | 40 | 4 | MP:0000823 | |
| MousePheno | respiratory failure | 1.23e-03 | 165 | 40 | 4 | MP:0001953 | |
| Domain | Growth_fac_rcpt_ | 1.59e-07 | 156 | 49 | 7 | IPR009030 | |
| Domain | EGF-like_dom | 2.51e-07 | 249 | 49 | 8 | IPR000742 | |
| Domain | EGF | 2.50e-06 | 235 | 49 | 7 | SM00181 | |
| Domain | ASX_HYDROXYL | 6.29e-06 | 100 | 49 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.37e-06 | 106 | 49 | 5 | IPR000152 | |
| Domain | Furin_repeat | 1.35e-05 | 18 | 49 | 3 | IPR006212 | |
| Domain | FU | 1.35e-05 | 18 | 49 | 3 | SM00261 | |
| Domain | EGF_CA | 1.66e-05 | 122 | 49 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.80e-05 | 124 | 49 | 5 | IPR001881 | |
| Domain | MYT1 | 2.02e-05 | 3 | 49 | 2 | PF08474 | |
| Domain | Myelin_TF | 2.02e-05 | 3 | 49 | 2 | IPR013681 | |
| Domain | Tyr_kinase_insulin-like_rcpt | 2.02e-05 | 3 | 49 | 2 | IPR016246 | |
| Domain | EGF_3 | 3.31e-05 | 235 | 49 | 6 | PS50026 | |
| Domain | cEGF | 4.23e-05 | 26 | 49 | 3 | IPR026823 | |
| Domain | cEGF | 4.23e-05 | 26 | 49 | 3 | PF12662 | |
| Domain | EGF_1 | 5.22e-05 | 255 | 49 | 6 | PS00022 | |
| Domain | EGF-like_CS | 5.94e-05 | 261 | 49 | 6 | IPR013032 | |
| Domain | EGF_2 | 6.46e-05 | 265 | 49 | 6 | PS01186 | |
| Domain | EGF_CA | 7.58e-05 | 86 | 49 | 4 | PF07645 | |
| Domain | Znf_C2HC | 1.00e-04 | 6 | 49 | 2 | IPR002515 | |
| Domain | zf-C2HC | 1.00e-04 | 6 | 49 | 2 | PF01530 | |
| Domain | PROTEIN_KINASE_TYR | 1.21e-04 | 97 | 49 | 4 | PS00109 | |
| Domain | EGF_Ca-bd_CS | 1.21e-04 | 97 | 49 | 4 | IPR018097 | |
| Domain | Tyr_kinase_AS | 1.21e-04 | 97 | 49 | 4 | IPR008266 | |
| Domain | EGF_CA | 1.31e-04 | 99 | 49 | 4 | PS01187 | |
| Domain | Furin-like | 1.40e-04 | 7 | 49 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.40e-04 | 7 | 49 | 2 | IPR000494 | |
| Domain | ZF_CCHHC | 1.40e-04 | 7 | 49 | 2 | PS51802 | |
| Domain | Furin-like_Cys-rich_dom | 1.40e-04 | 7 | 49 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 1.40e-04 | 7 | 49 | 2 | PF01030 | |
| Domain | - | 1.40e-04 | 7 | 49 | 2 | 3.80.20.20 | |
| Domain | Peptidase_M12B_N | 1.45e-04 | 39 | 49 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.45e-04 | 39 | 49 | 3 | PF01562 | |
| Domain | - | 1.45e-04 | 39 | 49 | 3 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 1.57e-04 | 40 | 49 | 3 | PS00427 | |
| Domain | Reprolysin | 1.57e-04 | 40 | 49 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.57e-04 | 40 | 49 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.57e-04 | 40 | 49 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.57e-04 | 40 | 49 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 1.69e-04 | 41 | 49 | 3 | IPR001762 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.38e-04 | 46 | 49 | 3 | IPR011042 | |
| Domain | EGF | 3.31e-04 | 126 | 49 | 4 | PF00008 | |
| Domain | Tyr_kinase_rcpt_2_CS | 3.65e-04 | 11 | 49 | 2 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 4.38e-04 | 12 | 49 | 2 | PS00239 | |
| Domain | Ldl_recept_b | 6.01e-04 | 14 | 49 | 2 | PF00058 | |
| Domain | LDLRB | 6.01e-04 | 14 | 49 | 2 | PS51120 | |
| Domain | LY | 6.93e-04 | 15 | 49 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.93e-04 | 15 | 49 | 2 | IPR000033 | |
| Domain | PLAC | 1.12e-03 | 19 | 49 | 2 | PS50900 | |
| Domain | PLAC | 1.12e-03 | 19 | 49 | 2 | IPR010909 | |
| Domain | MetalloPept_cat_dom | 1.25e-03 | 81 | 49 | 3 | IPR024079 | |
| Domain | - | 1.25e-03 | 81 | 49 | 3 | 3.40.390.10 | |
| Domain | ADAM_spacer1 | 1.65e-03 | 23 | 49 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.65e-03 | 23 | 49 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.79e-03 | 24 | 49 | 2 | IPR013273 | |
| Domain | - | 1.85e-03 | 679 | 49 | 7 | 3.30.160.60 | |
| Domain | zf-C2H2 | 2.08e-03 | 693 | 49 | 7 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.10e-03 | 694 | 49 | 7 | IPR013087 | |
| Domain | ZINC_PROTEASE | 2.17e-03 | 98 | 49 | 3 | PS00142 | |
| Domain | TUDOR | 2.27e-03 | 27 | 49 | 2 | SM00333 | |
| Domain | Tudor | 2.80e-03 | 30 | 49 | 2 | IPR002999 | |
| Domain | EGF_LAM_2 | 2.80e-03 | 30 | 49 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.80e-03 | 30 | 49 | 2 | PS01248 | |
| Domain | Laminin_EGF | 3.80e-03 | 35 | 49 | 2 | PF00053 | |
| Domain | EGF_Lam | 3.80e-03 | 35 | 49 | 2 | SM00180 | |
| Domain | ZINC_FINGER_C2H2_2 | 3.88e-03 | 775 | 49 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 3.93e-03 | 777 | 49 | 7 | PS00028 | |
| Domain | Laminin_EGF | 4.46e-03 | 38 | 49 | 2 | IPR002049 | |
| Domain | Znf_C2H2-like | 4.49e-03 | 796 | 49 | 7 | IPR015880 | |
| Domain | Pkinase_Tyr | 4.70e-03 | 129 | 49 | 3 | PF07714 | |
| Domain | Znf_C2H2 | 4.77e-03 | 805 | 49 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 4.87e-03 | 808 | 49 | 7 | SM00355 | |
| Domain | LDLR_class-A_CS | 4.94e-03 | 40 | 49 | 2 | IPR023415 | |
| Domain | CYSTEINE_SWITCH | 5.18e-03 | 41 | 49 | 2 | PS00546 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.63e-08 | 258 | 39 | 9 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.61e-08 | 300 | 39 | 9 | M610 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.56e-05 | 76 | 39 | 4 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.08e-04 | 90 | 39 | 4 | M631 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 4.30e-04 | 129 | 39 | 4 | M39693 | |
| Pubmed | 2.72e-09 | 251 | 50 | 8 | 29031500 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRR12 FLNA FRAS1 IGF1R ZNF48 CELSR2 PIK3C2B RTTN LMTK2 LRP4 PRAG1 | 3.80e-07 | 1105 | 50 | 11 | 35748872 |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 1.26e-06 | 15 | 50 | 3 | 38871984 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19139090 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22438913 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35964946 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12813019 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21474992 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28050756 | ||
| Pubmed | Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. | 2.03e-06 | 2 | 50 | 2 | 16642022 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28407051 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26438154 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 38383709 | ||
| Pubmed | Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. | 2.03e-06 | 2 | 50 | 2 | 23671263 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24809298 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31088290 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26862994 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18708119 | ||
| Pubmed | A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. | 2.03e-06 | 2 | 50 | 2 | 21139139 | |
| Pubmed | The insulin and IGF1 receptor kinase domains are functional dimers in the activated state. | 2.03e-06 | 2 | 50 | 2 | 25758790 | |
| Pubmed | Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. | 2.03e-06 | 2 | 50 | 2 | 16644916 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 1660482 | ||
| Pubmed | Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors. | 2.03e-06 | 2 | 50 | 2 | 29291346 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25246545 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27384680 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35786404 | ||
| Pubmed | Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. | 2.03e-06 | 2 | 50 | 2 | 27207510 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28138037 | ||
| Pubmed | Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function. | 2.03e-06 | 2 | 50 | 2 | 27207537 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30070361 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25017244 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18711691 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31562314 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27088794 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 14722023 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17416680 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22692545 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26850678 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21177763 | ||
| Pubmed | Insulin, insulin receptor and insulin-like growth factor-I receptor on the human ocular surface. | 2.03e-06 | 2 | 50 | 2 | 12613967 | |
| Pubmed | Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. | 2.03e-06 | 2 | 50 | 2 | 18693051 | |
| Pubmed | Signalling through the insulin receptor and the insulin-like growth factor-I receptor. | 2.03e-06 | 2 | 50 | 2 | 7821728 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21908557 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19817984 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19744489 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28065828 | ||
| Pubmed | Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. | 2.03e-06 | 2 | 50 | 2 | 30765523 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24302626 | ||
| Pubmed | Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. | 2.03e-06 | 2 | 50 | 2 | 10073957 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26251471 | ||
| Pubmed | Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis. | 2.03e-06 | 2 | 50 | 2 | 25981038 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22879999 | ||
| Pubmed | Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling. | 2.03e-06 | 2 | 50 | 2 | 36548088 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17189427 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21524684 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22541124 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22825921 | ||
| Pubmed | A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. | 2.03e-06 | 2 | 50 | 2 | 7895674 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19851056 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28030849 | ||
| Pubmed | Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds. | 2.03e-06 | 2 | 50 | 2 | 28468775 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19835884 | ||
| Pubmed | Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. | 2.03e-06 | 2 | 50 | 2 | 16306401 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20620597 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19406949 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27905925 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19524295 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15063759 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18650937 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 34074726 | ||
| Pubmed | The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. | 2.03e-06 | 2 | 50 | 2 | 1326552 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30213860 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22161861 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17641087 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 32975906 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 29040448 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24970814 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28096258 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12734206 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28830678 | ||
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 4.26e-06 | 75 | 50 | 4 | 37298722 | |
| Pubmed | 4.28e-06 | 167 | 50 | 5 | 22159717 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31908002 | ||
| Pubmed | Insulin receptor-related receptor as an extracellular alkali sensor. | 6.07e-06 | 3 | 50 | 2 | 21641549 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 35921893 | ||
| Pubmed | The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. | 6.07e-06 | 3 | 50 | 2 | 25863161 | |
| Pubmed | MicroRNA 322 Aggravates Dexamethasone-Induced Muscle Atrophy by Targeting IGF1R and INSR. | 6.07e-06 | 3 | 50 | 2 | 32046161 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16831875 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 26475121 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 25269484 | ||
| Pubmed | Insulin regulates neurovascular coupling through astrocytes. | 6.07e-06 | 3 | 50 | 2 | 35858325 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27510031 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24683100 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 26584640 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 29518496 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9524259 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11071852 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9369444 | ||
| Pubmed | Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. | 6.07e-06 | 3 | 50 | 2 | 25643582 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11741898 | ||
| Interaction | NTN5 interactions | 3.16e-07 | 24 | 49 | 4 | int:NTN5 | |
| Interaction | LGALS1 interactions | 1.25e-06 | 332 | 49 | 8 | int:LGALS1 | |
| Interaction | ZFP41 interactions | 1.11e-05 | 57 | 49 | 4 | int:ZFP41 | |
| Interaction | VWCE interactions | 1.76e-05 | 64 | 49 | 4 | int:VWCE | |
| Interaction | ZNF408 interactions | 2.66e-05 | 145 | 49 | 5 | int:ZNF408 | |
| Interaction | ADAMTS4 interactions | 2.81e-05 | 72 | 49 | 4 | int:ADAMTS4 | |
| Interaction | IGFL3 interactions | 3.30e-05 | 75 | 49 | 4 | int:IGFL3 | |
| Interaction | FBLN5 interactions | 4.14e-05 | 159 | 49 | 5 | int:FBLN5 | |
| Interaction | APOH interactions | 5.24e-05 | 30 | 49 | 3 | int:APOH | |
| Interaction | ADAMTS1 interactions | 8.34e-05 | 95 | 49 | 4 | int:ADAMTS1 | |
| GeneFamily | Zinc fingers C2H2C-type | 1.29e-05 | 3 | 38 | 2 | 1261 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.02e-05 | 40 | 38 | 3 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.32e-04 | 57 | 38 | 3 | 1179 | |
| GeneFamily | Low density lipoprotein receptors | 3.31e-04 | 13 | 38 | 2 | 634 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 7.19e-04 | 19 | 38 | 2 | 50 | |
| GeneFamily | Tudor domain containing | 2.73e-03 | 37 | 38 | 2 | 780 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.58e-03 | 718 | 38 | 6 | 28 | |
| Coexpression | NABA_MATRISOME | FRAS1 COL16A1 IMPG1 ADAMDEC1 ADAMTS3 ACAN LPA NTNG1 LTBP1 ADAMTS14 CTSB MASP2 | 3.08e-07 | 1008 | 50 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME | FRAS1 COL16A1 IMPG1 ADAMDEC1 ADAMTS3 ACAN LPA NTNG1 LTBP1 ADAMTS14 CTSB MASP2 | 3.72e-07 | 1026 | 50 | 12 | M5889 |
| Coexpression | NABA_ECM_REGULATORS | 5.99e-06 | 238 | 50 | 6 | M3468 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES | 6.28e-06 | 240 | 50 | 6 | M40250 | |
| Coexpression | NABA_ECM_REGULATORS | 6.59e-06 | 242 | 50 | 6 | MM17062 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 | 9.24e-06 | 69 | 50 | 4 | M1145 | |
| Coexpression | NABA_CORE_MATRISOME | 1.23e-05 | 270 | 50 | 6 | MM17057 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 | 1.29e-05 | 75 | 50 | 4 | MM868 | |
| Coexpression | NABA_CORE_MATRISOME | 1.36e-05 | 275 | 50 | 6 | M5884 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | 6.55e-05 | 534 | 50 | 7 | M12522 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 1.20e-04 | 50 | 50 | 3 | M2485 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_DN | 1.26e-04 | 256 | 50 | 5 | M828 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN | 1.65e-04 | 144 | 50 | 4 | M440 | |
| Coexpression | SU_LIVER | 1.87e-04 | 58 | 50 | 3 | M7054 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 1.97e-04 | 59 | 50 | 3 | MM952 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | FLNA P2RX1 ADAMTS3 ACAN INSR LRP2 NTNG1 LTBP1 ITGA4 CTSB SLC39A8 | 6.44e-06 | 905 | 50 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | ZNF627 SALL3 ZFHX4 ADAMTS3 SERTAD2 NTNG1 LTBP1 ITGA4 SLC39A8 RNF182 | 2.08e-05 | 836 | 50 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_200 | 6.98e-05 | 34 | 50 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_500 | 1.50e-04 | 114 | 50 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 1.55e-04 | 217 | 50 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.71e-04 | 118 | 50 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.83e-04 | 120 | 50 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-08 | 181 | 50 | 6 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-08 | 181 | 50 | 6 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 8.84e-08 | 197 | 50 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 8.84e-08 | 197 | 50 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-07 | 127 | 50 | 5 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.59e-06 | 176 | 50 | 5 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.59e-06 | 176 | 50 | 5 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-06 | 185 | 50 | 5 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-06 | 185 | 50 | 5 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-06 | 195 | 50 | 5 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-06 | 195 | 50 | 5 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 196 | 50 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 196 | 50 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-06 | 200 | 50 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-05 | 157 | 50 | 4 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-05 | 157 | 50 | 4 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 50 | 4 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 50 | 4 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.20e-05 | 161 | 50 | 4 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-05 | 161 | 50 | 4 | 3e5a125a25d55bf27652f456239b00b315d54d91 | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.44e-05 | 164 | 50 | 4 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-05 | 164 | 50 | 4 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 167 | 50 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 167 | 50 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 168 | 50 | 4 | 6501495b7ad252af330b18011696c43031541018 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 168 | 50 | 4 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 168 | 50 | 4 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 171 | 50 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-05 | 171 | 50 | 4 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 171 | 50 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 171 | 50 | 4 | effcc4b6d26eafc2ca6fa08b6fee2689eff48f0f | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.24e-05 | 173 | 50 | 4 | 51328a60ffaf34fa0f7df6084d348b5efc9917f5 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.24e-05 | 173 | 50 | 4 | b77cd5dbda3a206922f20224f4e10a3bf712f7db | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.24e-05 | 173 | 50 | 4 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 176 | 50 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 176 | 50 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-05 | 176 | 50 | 4 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-05 | 176 | 50 | 4 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-05 | 179 | 50 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.84e-05 | 179 | 50 | 4 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 181 | 50 | 4 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 182 | 50 | 4 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 182 | 50 | 4 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 182 | 50 | 4 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 182 | 50 | 4 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 182 | 50 | 4 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 182 | 50 | 4 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_2|World / Lineage and Cell class | 5.16e-05 | 182 | 50 | 4 | a7e7aa10f14111a6c7ba22e0f1668dcaa124714d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.50e-05 | 185 | 50 | 4 | 29d7ddcb9a2e45f76cd5611f7c52b6df689effd3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.50e-05 | 185 | 50 | 4 | 780bdb63ef913a09930063286011c9108381d3a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.50e-05 | 185 | 50 | 4 | 274b8acccdfe434d14af4cb32fb615c06ec98435 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.50e-05 | 185 | 50 | 4 | b640d9ed6a1e6aa595053065bb992efc0402353e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.73e-05 | 187 | 50 | 4 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.85e-05 | 188 | 50 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 188 | 50 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 188 | 50 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.85e-05 | 188 | 50 | 4 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 188 | 50 | 4 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 190 | 50 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 190 | 50 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 190 | 50 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 191 | 50 | 4 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.22e-05 | 191 | 50 | 4 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 191 | 50 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | LA-05._Cytoplasmic_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.22e-05 | 191 | 50 | 4 | d825e55278dce666c332cc060d1255659e07e568 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.22e-05 | 191 | 50 | 4 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-05 | 192 | 50 | 4 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.35e-05 | 192 | 50 | 4 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Control-Myeloid-MoAM4|Control / Disease group,lineage and cell class （2021.01.30） | 6.35e-05 | 192 | 50 | 4 | 1da7c303a2e36af4a9d8ec30a11380d9b1897922 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-05 | 193 | 50 | 4 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 193 | 50 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-05 | 193 | 50 | 4 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.48e-05 | 193 | 50 | 4 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 6.48e-05 | 193 | 50 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.48e-05 | 193 | 50 | 4 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 50 | 4 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 50 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LA-05._Cytoplasmic_Cardiomyocyte_I|LA / Chamber and Cluster_Paper | 6.61e-05 | 194 | 50 | 4 | e4b3a896e79666a935171af05c8d0b68de4fee32 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.61e-05 | 194 | 50 | 4 | f1cabb198ab32deaf299899c5e8f42d861b8c574 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 50 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 50 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 50 | 4 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 50 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 50 | 4 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 195 | 50 | 4 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | distal-1-Hematologic-Nonclassical_Monocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.74e-05 | 195 | 50 | 4 | e1a8171d1af53c2bbda758170c5053d3a3bb6ddd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 195 | 50 | 4 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| Drug | Insulin recombinant | 2.16e-06 | 12 | 50 | 3 | DB00030 | |
| Drug | Insulin, porcine | 2.81e-06 | 13 | 50 | 3 | DB00071 | |
| Drug | ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A | 4.63e-06 | 198 | 50 | 6 | 6197_UP | |
| Drug | Insulin Glargine | 4.73e-06 | 2 | 50 | 2 | ctd:D000069036 | |
| Drug | Insulin Lispro | 4.73e-06 | 2 | 50 | 2 | DB00046 | |
| Drug | Insulin Glargine | 4.73e-06 | 2 | 50 | 2 | DB00047 | |
| Drug | Mecasermin | 1.42e-05 | 3 | 50 | 2 | DB01277 | |
| Drug | AC1L1GKK | 2.83e-05 | 4 | 50 | 2 | CID000003725 | |
| Drug | chondroitin sulfate | 3.13e-05 | 413 | 50 | 7 | CID000024766 | |
| Drug | monatepil | 3.50e-05 | 29 | 50 | 3 | CID000060810 | |
| Drug | PQ401 | 4.71e-05 | 5 | 50 | 2 | CID009549305 | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; HL60; HG-U133A | 6.95e-05 | 196 | 50 | 5 | 2036_UP | |
| Drug | AC1L1CTI | 7.05e-05 | 6 | 50 | 2 | CID000002057 | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 4186_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; PC3; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 4226_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | 7.29e-05 | 198 | 50 | 5 | 1553_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 3073_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 6080_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; MCF7; HT_HG-U133A | 7.65e-05 | 200 | 50 | 5 | 2642_UP | |
| Drug | pp175 | 9.86e-05 | 7 | 50 | 2 | CID000006543 | |
| Disease | body weight | MYT1L IGF1R COL16A1 ADAMTS3 ACAN RTTN INSR NTNG1 LTBP1 ADAMTS14 KDM4B | 4.38e-06 | 1261 | 48 | 11 | EFO_0004338 |
| Disease | breast cancer (is_marker_for) | 1.26e-05 | 185 | 48 | 5 | DOID:1612 (is_marker_for) | |
| Disease | vital capacity | NCOA3 IGF1R ADAMTS3 PIK3C2B ACAN MYT1 LRP2 LTBP1 SLC39A8 KDM4B | 2.45e-05 | 1236 | 48 | 10 | EFO_0004312 |
| Disease | gestational diabetes (biomarker_via_orthology) | 2.58e-05 | 5 | 48 | 2 | DOID:11714 (biomarker_via_orthology) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.55e-05 | 121 | 48 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | high grade glioma (implicated_via_orthology) | 5.11e-05 | 44 | 48 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.50e-05 | 127 | 48 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | uric acid measurement | 5.50e-05 | 610 | 48 | 7 | EFO_0004761 | |
| Disease | choline measurement | 6.02e-05 | 130 | 48 | 4 | EFO_0010116 | |
| Disease | body surface area | 7.66e-05 | 643 | 48 | 7 | EFO_0022196 | |
| Disease | TPE interval measurement | 8.44e-05 | 52 | 48 | 3 | EFO_0004644 | |
| Disease | alcohol dependence (implicated_via_orthology) | 9.26e-05 | 9 | 48 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.30e-04 | 60 | 48 | 3 | EFO_0022282 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 1.41e-04 | 162 | 48 | 4 | EFO_0004612, EFO_0007878 | |
| Disease | sleep disorder (implicated_via_orthology) | 1.41e-04 | 11 | 48 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in IDL percentage | 1.50e-04 | 63 | 48 | 3 | EFO_0022329 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 1.62e-04 | 168 | 48 | 4 | EFO_0004329, EFO_0004612 | |
| Disease | total lipids in very large HDL measurement | 1.72e-04 | 66 | 48 | 3 | EFO_0022312 | |
| Disease | cholesterol in very large HDL measurement | 1.96e-04 | 69 | 48 | 3 | EFO_0022229 | |
| Disease | Mammary Carcinoma, Human | 2.01e-04 | 525 | 48 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.01e-04 | 525 | 48 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 2.05e-04 | 527 | 48 | 6 | C1458155 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.10e-04 | 335 | 48 | 5 | EFO_0009931 | |
| Disease | Breast Carcinoma | 2.29e-04 | 538 | 48 | 6 | C0678222 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.33e-04 | 14 | 48 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.33e-04 | 14 | 48 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.41e-04 | 74 | 48 | 3 | EFO_0022280 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.68e-04 | 15 | 48 | 2 | EFO_0007804, GO_0036273 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 3.06e-04 | 16 | 48 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.47e-04 | 17 | 48 | 2 | EFO_0022232 | |
| Disease | theta wave measurement | 3.47e-04 | 17 | 48 | 2 | EFO_0006873 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.63e-04 | 85 | 48 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | schizophrenia, inflammatory bowel disease | 3.90e-04 | 18 | 48 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | lipid measurement, lipoprotein measurement | 4.30e-04 | 90 | 48 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | Congenital hernia of foramen of Morgagni | 4.35e-04 | 19 | 48 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 4.35e-04 | 19 | 48 | 2 | C0265700 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.68e-04 | 222 | 48 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.83e-04 | 20 | 48 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.84e-04 | 224 | 48 | 4 | EFO_0004530, EFO_0008317 | |
| Disease | Congenital diaphragmatic hernia | 5.34e-04 | 21 | 48 | 2 | C0235833 | |
| Disease | stroke, coronary artery disease | 5.34e-04 | 21 | 48 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 5.34e-04 | 21 | 48 | 2 | EFO_0022246 | |
| Disease | urate measurement | 5.74e-04 | 895 | 48 | 7 | EFO_0004531 | |
| Disease | Lewy Body Disease | 5.86e-04 | 22 | 48 | 2 | C0752347 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 6.37e-04 | 103 | 48 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 6.41e-04 | 23 | 48 | 2 | OBA_2045181 | |
| Disease | fatty acid measurement | 6.99e-04 | 436 | 48 | 5 | EFO_0005110 | |
| Disease | breast cancer (implicated_via_orthology) | 7.59e-04 | 25 | 48 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | large artery stroke, coronary artery disease | 7.59e-04 | 25 | 48 | 2 | EFO_0001645, EFO_0005524 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 7.92e-04 | 111 | 48 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 8.21e-04 | 26 | 48 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement | 8.45e-04 | 260 | 48 | 4 | EFO_0008317 | |
| Disease | Beta blocking agent use measurement | 8.56e-04 | 114 | 48 | 3 | EFO_0009929 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.95e-04 | 264 | 48 | 4 | EFO_0008317, EFO_0020944 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 9.53e-04 | 28 | 48 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | complex trait | 9.86e-04 | 271 | 48 | 4 | EFO_0010578 | |
| Disease | diabetes mellitus (is_implicated_in) | 1.02e-03 | 29 | 48 | 2 | DOID:9351 (is_implicated_in) | |
| Disease | longevity, healthspan, parental longevity | 1.02e-03 | 29 | 48 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 1.04e-03 | 122 | 48 | 3 | EFO_0004318, EFO_0007789 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.07e-03 | 123 | 48 | 3 | EFO_0007789, EFO_0008002 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.17e-03 | 31 | 48 | 2 | EFO_0022249 | |
| Disease | aortic stenosis | 1.17e-03 | 31 | 48 | 2 | EFO_0000266 | |
| Disease | esterified cholesterol measurement | 1.20e-03 | 128 | 48 | 3 | EFO_0008589 | |
| Disease | polyunsaturated fatty acid measurement | 1.28e-03 | 131 | 48 | 3 | EFO_0010733 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.32e-03 | 33 | 48 | 2 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Complement deficiency disease | 1.32e-03 | 33 | 48 | 2 | C0272242 | |
| Disease | hyperuricemia | 1.32e-03 | 33 | 48 | 2 | EFO_0009104 | |
| Disease | left ventricular mass index | 1.41e-03 | 34 | 48 | 2 | EFO_0009290 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.41e-03 | 34 | 48 | 2 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.41e-03 | 34 | 48 | 2 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | phospholipid measurement | 1.55e-03 | 140 | 48 | 3 | EFO_0004639 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.56e-03 | 307 | 48 | 4 | EFO_0004612, EFO_0020946 | |
| Disease | atopic eczema, psoriasis | 1.58e-03 | 36 | 48 | 2 | EFO_0000274, EFO_0000676 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.58e-03 | 36 | 48 | 2 | EFO_0022257 | |
| Disease | Eczema | 1.62e-03 | 310 | 48 | 4 | HP_0000964 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECSSPPSCKRKVGGT | 361 | Q99728 | |
| PPCTGEGDTPKCSKI | 196 | P07858 | |
| KPGVKGEKGDPCEVC | 496 | Q07092 | |
| PAGIKGAKGEPCEPC | 621 | Q07092 | |
| PKGEKGDGCTACPSL | 716 | Q07092 | |
| GSGPCKTRDDEPVCG | 136 | Q9HDC9 | |
| GTVPGCPAKKNVCDS | 1566 | Q9HCU4 | |
| DTSPPCLGGNKKTLG | 121 | Q9Y3E2 | |
| CKTKKGPPLDGTECA | 516 | Q8WXS8 | |
| SKTCGPITLPGEKNC | 66 | Q06432 | |
| APSHCTGCKKPEEGL | 666 | Q86XX4 | |
| EPGLCGPGTKECEVL | 726 | Q17R60 | |
| GNKPPKECGDLCPGT | 171 | P08069 | |
| CEVDGKPQPSVKCVG | 596 | Q9UMF0 | |
| CPKGKGFVPAGESSS | 1401 | Q14766 | |
| KEAPIASLGKGCPAT | 701 | O94953 | |
| TPTKELGPCGGEACG | 1371 | Q8IWU2 | |
| LIKPGGKGFTCECPD | 3481 | P98164 | |
| CPGTAKGKTNCPATV | 186 | P06213 | |
| LPFTCKKGTVACGEP | 2436 | P16112 | |
| SPGPGDIEGSCKKLS | 141 | O00750 | |
| GCPEKESEEGCPKRG | 461 | O43719 | |
| CKTKKGPPLDGTECA | 516 | O15072 | |
| PCFDASKVKCSGPGL | 1156 | P21333 | |
| GPTSSDKGGVKEAPC | 221 | Q8IYS4 | |
| VEPKKCPGSIVGGCV | 1811 | P08519 | |
| SKGEKSLPVCEPVCG | 421 | O00187 | |
| LGSPNGEPCGKTCLE | 106 | P13612 | |
| TEPPQCKDSTGKCGP | 196 | Q03591 | |
| RGKCPSTVCGVCGKP | 971 | Q9BXA9 | |
| PCTPKGCLELIKETG | 146 | P11586 | |
| KTGTTGPKCDECLPG | 441 | Q9Y2I2 | |
| PEGGICKEDSGCTPG | 121 | P51575 | |
| LKGCPGPCGVTLKSL | 1106 | Q86VV8 | |
| PCDTPGQGLTCSGEK | 21 | Q9Y6Q9 | |
| LTCGGKGKKCLPENP | 91 | Q8N6D2 | |
| ESEGLGLGCPSPCKR | 1351 | Q9ULL5 | |
| EPGCTKVPEPGCTKV | 71 | Q9UBC9 | |
| GCTKVPEPGCTKVPE | 81 | Q9UBC9 | |
| TCKLKPGTDCGGDAP | 451 | O15204 | |
| DGSPGSGIECPKCDT | 606 | Q86UP3 | |
| GTEGTKPECTLCGVK | 2956 | Q86UP3 | |
| PGTTSCPECGKTSLK | 176 | Q8N0Y2 | |
| PAGERPTICGECGKS | 186 | Q96MX3 | |
| GLEGKIVSPCDGPSK | 16 | Q14140 | |
| PGVKPCESSVCGEVG | 96 | Q7L945 | |
| GVPGEEPKCNICLGK | 91 | Q5T6S3 | |
| EKRGPSFPKECCSQG | 301 | Q86YV5 | |
| TPPADGKRFGCLCGK | 376 | Q96C00 | |
| KLRPFGCPAEGCGKS | 326 | P98168 | |
| DGKKEPSSCTCLKGP | 281 | Q9C0K1 | |
| PTGIQLKGDGKTCDP | 1336 | O75096 | |
| KKESKCPTPGCDGTG | 501 | Q9UL68 | |
| EKREIKCPTPGCDGT | 436 | Q01538 |